AFP and liver cancer: Staging systems such as the Barcelona Clinic Liver Cancer (BCLC) evaluate these aspects, along with objective scores like the Model for End-stage Liver Disease (MELD), the albumin–bilirubin (ALBI) score, and biomarkers such as alpha-fetoprotein (AFP) [11,12].